benzocaine has been researched along with Obesity in 6 studies
Benzocaine: A surface anesthetic that acts by preventing transmission of impulses along NERVE FIBERS and at NERVE ENDINGS.
dextran sulfate sodium : An organic sodium salt of dextran sulfate. It induces colitis in mice.
benzocaine : A benzoate ester having 4-aminobenzoic acid as the acid component and ethanol as the alcohol component. A surface anaesthetic, it is used to suppress the gag reflex, and as a lubricant and topical anaesthetic on the larynx, mouth, nasal cavity, respiratory tract, oesophagus, rectum, urinary tract, and vagina.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phenylpropanolamine (PPA) and benzocaine are non-prescription medications approved for treating obesity." | 5.09 | Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity. ( Greenway, F; Herber, D; Morales, S; Raum, W, 1999) |
| "In a single-blinded, randomized, cross-over design, subjects with or without obesity (n = 14 and n = 11, respectively) were infused intraduodenally with saline or a combination of glucose and oleic acid for 90 min (glucose load: 22." | 4.31 | Intraduodenal nutrient infusion differentially alters intestinal nutrient sensing, appetite, and satiety responses in lean and obese subjects. ( Abumrad, NN; Antoun, J; Dixon, KB; Dole, M; Flynn, CR; Johnson, C; Kilkelly, D; Sundaresan, S; Tamboli, R, 2023) |
| "Pharmacological treatment of obesity has been neglected as a viable therapeutic option for many years." | 2.39 | Combined drug treatment of obesity. ( Atkinson, RL; Blank, RC; Loper, JF; Lutes, RA; Schumacher, D, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sundaresan, S | 1 |
| Johnson, C | 1 |
| Dixon, KB | 1 |
| Dole, M | 1 |
| Kilkelly, D | 1 |
| Antoun, J | 1 |
| Flynn, CR | 1 |
| Abumrad, NN | 1 |
| Tamboli, R | 1 |
| Heim, HC | 1 |
| Atkinson, RL | 1 |
| Blank, RC | 1 |
| Loper, JF | 1 |
| Schumacher, D | 1 |
| Lutes, RA | 1 |
| Greenway, F | 1 |
| Herber, D | 2 |
| Raum, W | 1 |
| Morales, S | 1 |
| Greenway, FL | 1 |
2 reviews available for benzocaine and Obesity
| Article | Year |
|---|---|
Combined drug treatment of obesity.
Topics: Adrenergic Agents; Appetite Depressants; Benzocaine; Drug Therapy, Combination; Ephedrine; Fenfluram | 1995 |
Clinical studies with phenylpropanolamine: a metaanalysis.
Topics: Appetite Depressants; Benzocaine; Drug Therapy, Combination; Humans; Meta-Analysis as Topic; Obesity | 1992 |
2 trials available for benzocaine and Obesity
| Article | Year |
|---|---|
Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity.
Topics: Adolescent; Adult; Aged; Appetite Depressants; Benzocaine; Delayed-Action Preparations; Dose-Respons | 1999 |
A nasal decongestant and a local anesthetic for weight control?
Topics: Benzocaine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Obesity; Phenylprop | 1979 |
2 other studies available for benzocaine and Obesity
| Article | Year |
|---|---|
Intraduodenal nutrient infusion differentially alters intestinal nutrient sensing, appetite, and satiety responses in lean and obese subjects.
Topics: Appetite; Benzocaine; Gastrointestinal Hormones; Humans; Nutrients; Obesity; Oleic Acid; Satiety Res | 2023 |
O-T-C drugs in control of obesity.
Topics: Agar; Appetite; Appetite Regulation; Benzocaine; Diet, Reducing; Humans; Methylcellulose; Obesity; R | 1967 |